GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP

GSK plc (GSK) announced that the U.S. Centers for Disease Control and Prevention’s (“CDC”) Advisory Committee on Immunization Practices (“ACIP”) voted favorably, recommending the use of Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) as part of the adolescent meningococcal vaccination schedule.ACIP has recommended a single dose of Penmenvy to protect individuals of more than 10 years of age in the United States against disease-causing serogroups of Neisseria meningitidis (A, B, C, W and Y). The re ...